MONDAY, FEB 20 - 8pm EST
http://www.ancan.org/bat-presentation
Bipolar Androgen Therapy (BAT) is one of the hottest topics in prostate cancer right now for men with metastatic disease. Counter intuitive as it is, trials have shown large doses of testosterone followed by hormone therapy or chemotherapy appear to be very effective for some men in reducing PSA - for an excellent commentary by Mike Scott on Prostate Cancer International, click here.
https://prostatecancerinfolink.net/2016/12/05/can-bipolar-cycling-of-testosterone-really-cure-prostate-cancer/
Dr. Sam Denmeade at Johns Hopkins is in the forefront of this research. This coming Monday, February 20 at 8pm EST, Dr. Denmeade will explain his research and
open clinical trials on Answer Cancer Foundation's UsTOO Hi-risk/Recurrent/Advanced Prostate Cancer Virtual Support Group meeting (www.ancan.org/support-calls). Attendance is free and all are welcome.
To learn how to join the meeting click www.ancan.org/joining-instructions or see below. You can attend online via GoToMeeting or join by phone. The number of online participants is limited, but phone-ins are not - if the room is full, please use phone access. For more information please e-mail
[email protected].
JOINING INSTRUCTIONS
COMPUTER, TABLET OR SMARTPHONE
Click on this link below or paste into your browser:
https://www.gotomeet.me/AnswerCancer
You will be using your microphone and speakers (VoIP).
A USB headset is recommended for the best sound quality.
To minimize background noise, please mute your mic when not speaking
DIAL-IN PHONE
• United States +1 (646) 749-3129
• Canada +1 (647) 497-9353
• Australia +61 2 8355 1020
Access Code: 222-583-973
Post Edited (ardeee) : 2/18/2017 10:46:59 AM (GMT-7)